Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Knowing what to look for in no fee credit cards with benefits can enhance your financial strategy. Discover essential features to consider.
19,441 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Bitcoin dipped over the weekend, but traders rotated into infrastructure-focused bets as the Bitcoin Hyper presale su...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
A new study shows CFOs report productivity boosts from AI, but revenue gains lag behind, hinting at a one-year delay ...
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
Ripple announces a security collaboration with Crypto ISAC to share North Korea-linked threat intel, aiming to streng...
Uber’s first-quarter results sparked a rare split on Wall Street: Goldman Sachs trims the stock target, while Piper S...
Gary Vaynerchuk is delivering a blunt rallying cry on AI: dedicate at least an hour daily to hands-on AI work. The me...
A high-income professional taps a tax-smart 401(k) path—after-tax contributions plus in-plan Roth conversions—to turn...
New risk signals emerge as the S&P 500 grows more concentrated. Top 10 names and chipmakers now drive most of the mar...
A niche ETF that pays monthly dividends on small and mid-cap REITs is bracing for a refinancing squeeze as rates stay...